Vicks DayQuil and Vicks NyQuil Cherry
- Product NDC
- 37000-031
- 11-digit product format
- 370000031
- Labeler code
- 37000
- Product ID
- 37000-031_f1755fe2-20c9-5735-e053-2995a90aa3fc
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Acetaminophen, Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride, and Doxylamine Succinate
- Dosage form
- KIT
- Route
- ORAL
- Labeler
- The Procter & Gamble Manufacturing Company
- Application
- M012
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2013-07-01
- Marketing end
- 0000-00-00
- Active strength
- 0
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 37000-031 | D | Discontinued by firm | 2026-10-23 | ||
| excluded package | package | 37000-031 | 37000-031-12 | D | Discontinued by firm | 2026-10-23 | |
| excluded package | package | 37000-031 | 37000-031-24 | D | Discontinued by firm | 2026-10-23 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 37000-031-24 | d630ba8d3edf… | 732f749b63fb… |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 37000-031-12 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 37000-031-24 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 37000-031-12 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 37000-031-24 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 37000-031-12 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 37000-031-24 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 37000-031-12 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 37000-031-24 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 37000-031-12 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 37000-031-24 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 37000-031-12 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 37000-031-24 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 37000-031-12 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 37000-031-24 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 37000-031-12 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 37000-031-24 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 37000-031-12 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 37000-031-24 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 37000-031-12 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 37000-031-24 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 37000-031-12 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 37000-031-24 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 37000-031-12 | 557ba5c1ecfa… | 9c80585c8c6e… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 37000-031-24 | 2021-02-12 | C162847 | 48780-1 | ba0f9c33-1e74-a910-e053-dadaa90a0b85 | Vicks ® DayQuil ™ & Vicks ® NyQuil ™ Cold and Flu Convenience Pack |
| 37000-031-24 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-1e74-a910-e053-dadaa90a0b85 | Vicks ® DayQuil ™ & Vicks ® NyQuil ™ Cold and Flu Convenience Pack |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Right Remedies Adult Long Lasting Cough Relief Softgel | DEXTROMETHORPHAN HYDROBROMIDE | Strive Pharmaceuticals Inc. | e3ea468e-4e12-4dae-b222-8e32456b77b8 | 2025-01-02 | Warnings | M012 |
| AVON HeXashield Congestion Relief Original | OXYMETAZOLINE HYDROCHLORIDE | Tai Guk Pharm. Co., Ltd. | 8f2c152c-c564-0cba-e053-2a95a90ab3c7 | 2025-01-01 | Warnings | M012 |
| Multi-Symptom Nighttime Cold and Flu Relief | ACETAMINOPHEN, DOXYLAMINE SUCCINATE, DEXTROMETHORPHAN HBR | Advanced Rx LLC | a75553bd-f3f0-47bd-b3c3-aeeb0d1a81b4 | 2025-01-01 | Warnings | M012 |
| Cough Relief | DEXTROMETHORPHAN HYDROBROMIDE | Advanced Rx LLC | 297e10e3-e740-4434-91a2-2e5c54985d33 | 2025-01-01 | Warnings | M012 |
| MUCUS RELIEF DM | GUAIFENESIN, DEXTROMETHORPHAN HBR | Advanced Rx LLC | 64620186-a45b-4c35-a3b9-a347348f93f7 | 2025-01-01 | Warnings | M012 |
| DM Max | DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | Best Choice | 57a44bbf-a304-47b9-8adc-4442c7787853 | 2025-01-01 | Warnings | M012 |
| Long Acting Cough Softgels | DEXTROMETHORPHAN HYDROBROMIDE | CVS PHARMACY, INC | 322daee6-c61d-43d3-a54d-a354fd3df242 | 2025-01-01 | Warnings | M012 |
| Adult Tussin DM Lil Drug Store Products | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | Lil' Drug Store Products, Inc | 1915cf2a-ebaa-4c47-8991-5b741fa01be2 | 2024-12-31 | Warnings | M012 |
| Congestion Relief Lil Drug Store Products | OXYMETAZOLINE HYDROCHLORIDE | Lil' Drug Store Products, Inc | 8fca348c-ecb6-4a91-89dd-8bd4c05ac745 | 2024-12-31 | Warnings | M012 |
| DAYTIME COLD AND FLU MULTI SYMPTOM | DAYTIME COLD AND FLU MULTI SYMPTOM | TARGET CORP | 9dea350d-2f09-b944-e053-2995a90a2b63 | 2024-12-30 | Warnings | M012 |
| Allergy Relief | DIPHENHYDRAMINE HYDROCHLORIDE | Walgreens | 2b7aa3f5-3bc9-471f-8ff7-3c52719f0acb | 2024-12-30 | Warnings | M012 |
| Pediacare Childrens Cough and Cold Grape | BROMPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | fabafdc1-9dd8-4258-af49-bab1e29ad109 | 2024-12-30 | Warnings | M012 |
| Pediacare Childrens Cough and Congestion Grape | DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN | RANDOB LABS,LTD. DBA CROSSINGWELL CONSUMER HEALTH | 9576723b-748c-45e7-bc0d-cc109b9f6735 | 2024-12-30 | Warnings | M012 |
| Cold and Flu Nighttime Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | Lil' Drug Store Products, Inc. | ef6836fa-d104-d7b3-e053-2a95a90af2b8 | 2024-12-30 | Warnings | M012 |
| Circle K Congestion Relief | OXYMETAZOLINE HYDROCHLORIDE | Lil' Drug Store Products, Inc | 7e02fe57-f42f-4d3c-9002-4c4c0b1fafd6 | 2024-12-30 | Warnings | M012 |
| SDA Laboratories Tussin | GUAIFENESIN | SDA Laboratories, Inc. | 2a444cc8-96be-9432-e063-6394a90a1b63 | 2024-12-27 | Warnings | M012 |
| SDA Laboratories Tussin DM | DEXTROMETHORPHAN HBR, GUAIFENESIN | SDA Laboratories, Inc. | 2a445f31-818d-11b1-e063-6294a90a8cb1 | 2024-12-27 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Richmond Pharmaceuticals Inc. | f184b2aa-91a4-44f9-b688-d4e318181984 | 2024-12-26 | Warnings | M012 |
| Diphenhydramine Hydrochloride | DIPHENHYDRAMINE HYDROCHLORIDE | Richmond Pharmaceuticals, Inc. | 2792032a-ff0f-4d5f-a8e3-b8b8c54f4e99 | 2024-12-26 | Warnings | M012 |
| OXYMETAZOLINE HYDROCHLORIDE | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION INC. | c7b1f980-9b0d-4f63-a70d-fd366658f863 | 2024-12-26 | Warnings | M012 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 37000-031-12 | 37000003112 | 1 KIT in 1 PACKAGE (37000-031-12) * 354 mL in 1 BOTTLE, PLASTIC (37000-555-12) * 354 mL in 1 BOTTLE, PLASTIC (37000-808-12) | 1 kit | 2021-07-13 | 0000-00-00 | No | No | Current |
| 37000-031-24 | 37000003124 | 1 KIT in 1 PACKAGE (37000-031-24) * 354 mL in 1 BOTTLE, PLASTIC (37000-555-12) * 354 mL in 1 BOTTLE, PLASTIC (37000-808-12) | 1 kit | 2013-07-01 | 0000-00-00 | No | No | Current |